Age-specific prevalence of human papillomavirus by grade of cervical cytology in Tibetan women

被引:0
|
作者
JIN Qiong SHEN Keng LI Hui ZHOU Xianrong HUANG Huifang and LENG Jinhua Department of Obstetrics and Gynecology Peking Union Medical College Hospital Department of Epidemiology institute of Basic Medical Sciences Peking Union Medical College Chinese Academy of Medical Sciences Beijing China Obstetrics and Gynecology Hospital of Fudan University Shanghai China [100730 ,200011 ]
机构
关键词
D O I
暂无
中图分类号
R686 [筋腱、韧带、滑囊疾病及损伤];
学科分类号
1002 ; 100210 ;
摘要
Background Human papillomavirus (HPV) is believed to be the most common sexually transmitted infection. However,little is known about the prevalence and distribution of HPV types in China. We aimed to assess the prevalence and thedistribution of HPV types as well as risks for abnormal cervical cytology in women who reside in the Tibetan AutonomousRegion of China.Methods Across-sectional study was performed involving a sample of 3036 women. An epidemiological questionnairewas applied and cervical specimens were obtained for liquid-based cytology and HPV DNA detection. Statistical analysisincluded chi-square and Logistic regression model.Results In this population, 3.66% (111/3036) had atypical squamous cells of undetermined significance (ASCUS),1.45% (44/3036) low-grade squamous intraepithelial lesions (LSIL) and 1.09% (33/3036) had high-grade squamousintraepithelial lesions (HSIL). Tibetan women (5.74%, 137/2387) exhibited lower abnormal cytology rates thannon-Tibetan women (8.01%, 52/649, P=0.03). The overall prevalence of HPV infection was 9.19% (279/3036). We failedto identify any differences in HPV prevalence by age. In the groups with normal, ASCUS, LSIL and HSIL, the overall HPVprevalences were 7.41% (211/2847), 24.32% (27/111), 56.82% (25/44) and 45.45% (15/33), respectively. HPV 16 (1.52%,46/3036) was the most common type, and was also the most prevalent in women with ASCUS (8.11%, 9/111) and HSIL(15.15%, 5/33). The most common HPV type for Tibetan women was HPV 16 (1.42%, 34/2387), whereas for non-Tibetanindividuals it was HPV 33 (2.31%, 15/649). Of the 279 HPV-infected women, 40 individuals (14.34%) presented withmultiple HPV positivity. Women who had two pregnancies were more likely to have abnormal cytology smear (Ofl=1.67;95% CI: 1.07-2.61).Conclusions A low prevalence of HPV positivity was observed in women who reside in the Tibetan AutonomousRegion of China. The prevalence of abnormal cervical cytology and HPV type distributions were different betweenTibetan and non-Tibetan women.
引用
收藏
页码:2004 / 2011
相关论文
共 50 条
  • [21] Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies
    Wei, Feixue
    Xia, Ningshao
    Ocampo, Rebeca
    Goodman, Marc T.
    Hessol, Nancy A.
    Grinsztejn, Beatriz
    Ortiz, Ana P.
    Zhao, Fanghui
    Kojic, Erna M.
    Kaul, Rupert
    Heard, Isabelle
    Morhason-Bello, Imran O.
    Moscicki, Anna-Barbara
    de Pokomandy, Alexandra
    Palefsky, Joel M.
    Rodrigues, Luana L. S.
    Mandishora, Racheal S. Dube
    Ramautarsing, Reshmie A.
    Franceschi, Silvia
    Godbole, Sheela, V
    Tso, Fernanda K.
    Menezes, Lynette J.
    Lin, Chunqing
    Clifford, Gary M.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (04) : 488 - 497
  • [22] Age-Specific Human Papillomavirus Antibody and Deoxyribonucleic Acid Prevalence: A Global Review
    Tiggelaar, Sarah M.
    Lin, Margaret J.
    Viscidi, Raphael P.
    Ji, Jia
    Smith, Jennifer S.
    JOURNAL OF ADOLESCENT HEALTH, 2012, 50 (02) : 110 - 131
  • [23] Molecular detection of human papillomavirus in women with minor-grade cervical cytology abnormalities
    Vince, A
    Ivanisevic, M
    Harni, V
    Skalko, D
    Jeren, T
    JOURNAL OF CLINICAL VIROLOGY, 2001, 20 (1-2) : 91 - 94
  • [24] Urine human papillomavirus prevalence in women with high-grade cervical lesions
    Nicolau, P.
    Mancebo, G.
    Agramunt, S.
    Sole-Sedeno, J. M.
    Bellosillo, B.
    Muset, M. M.
    Lloveras, B.
    Alameda, F.
    Carreras, R.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 183 : 12 - 15
  • [25] Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
    Leinonen, Maarit
    Nieminen, Pekka
    Kotaniemi-Talonen, Laura
    Malila, Nea
    Tarkkanen, Jussi
    Laurila, Pekka
    Anttila, Ahti
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23): : 1612 - 1623
  • [26] MANAGING WOMEN WITH HUMAN PAPILLOMAVIRUS CHANGES IN CERVICAL CYTOLOGY
    WINCESLAUS, SJ
    BROWN, C
    GOH, BT
    GENITOURINARY MEDICINE, 1988, 64 (04): : 259 - 262
  • [27] Type-Specific Human Papillomavirus Prevalence in Iranian Women with Normal Cervical Cytology: The Impact of Current HPV Vaccines
    Hamkar, Rasool
    Shoja, Zabihollah
    Ghavami, Nastaran
    Heydari, Nasrin
    Farahmand, Mohammad
    Jalilvand, Somayeh
    INTERVIROLOGY, 2017, 60 (04) : 125 - 130
  • [28] The Prevalence of Human Papillomavirus and Cervical Cytology Abnormalities in Women Infected with Human Immunodeficiency Virus in Southern Israel
    Leibenson, Lilach
    Banani, Shirly
    Borer, Avraham
    Meirovitz, Mihai
    Avni, Yonat Shemer
    Singer, Doron
    Schlaeffer, Francisc
    Leibenson, Max
    Silberstein, Tali
    Wiznitzer, Arnon
    Riesenberg, Klaris
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (01): : 34 - 38
  • [29] Prevalence and risk factors for human papillomavirus DNA in cervical cytology
    Kasap, Burcu
    Yetimalar, Hakan
    Keklik, Adnan
    Yildiz, Askin
    Cukurova, Kulal
    Soylu, Ferit
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 159 (01) : 168 - 171
  • [30] Type-specific prevalence of human papillomavirus among women with abnormal cytology in Jordan
    Freij, M. A.
    Saleh, H. H.
    Farsakh, H. A. A.
    Khadra, M. M.
    Ijmail, A. A.
    Rahall, B. O.
    Waldali, M. H.
    Najeeb, N. S.
    Tahtamouni, L. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (06) : 901 - 904